Analysis Group

It's the start of another one of our signature multi-episode series that we produce in collaboration with law firms and other organizations involved with FDA.

This series is being produced in collaboration with Analysis Group and in cooperation with White & Case.

and today's series kickoff will focus on rare diseases and real-world evidence.

On this podcast, we've discussed rare diseases and real-world evidence many times.

So let's meet our guests.

Our first guest is James Signorovich.

James is a managing principal at Analysis Group.

His practice spans clinical study design, external control development, natural history studies, the generation of regulatory-grade real-world evidence to support new product applications.